Corporate practices may not be in the midst of a booming fourth-quarter M&A market like the one that marked the end of 2012, but they have had a bright spot in 2013 thanks to the spate of IPO filings throughout the year.
And Pennsylvania firms have been cashing in on that work, due in large part to their industry expertise and geographic footprint. Area firms say they are seeing a lot of activity in the life sciences and biotechnology space, the busiest of all industries in the 2013 initial public offering market, and are leveraging their multi-office platforms to handle cross-border deals and those involving listings on more than one exchange.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
